Two centers in Argentina 🇦🇷 (@SinergiumBio) and Brazil 🇧🇷 (@BioFiocruz) are the first selected by PAHO to develop mRNA vaccines

Two centers in Argentina 🇦🇷 (@SinergiumBio) and Brazil 🇧🇷 (@BioFiocruz) are the first selected by PAHO to develop mRNA vaccines in Latin America.

The goal 🎯: to increase the region's capacity to respond to #COVID19 and future threats.

Learn more ➡️ paho.org/en/stories/vac… https://t.co/ll8BQIUDsb